MedPath

Renal Sympathetic Denervation in Mild Refractory Hypertension

Phase 4
Completed
Conditions
Refractory Hypertension
Interventions
Other: Sham procedure
Device: Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA)
Registration Number
NCT01656096
Lead Sponsor
University of Leipzig
Brief Summary

The purpose of this study is to examine the benefit of renal sympathetic denervation in patients with mild refractory hypertension

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
71
Inclusion Criteria
  • Refractory hypertension: 3 or more antihypertensive agents of different classes (including a diuretic) at optimal dosage without change in the 4 weeks preceding randomization
  • Systolic blood pressure of 135-149 and/or diastolic blood pressure of 90-94 mmHg (ABPM mean daytime values)
  • No change in blood pressure medication within 6 months after randomization
  • Age 18 to 75 years
  • Informed consent
Exclusion Criteria
  • Blood pressure outside range mentioned above
  • Renal, aortic or pelvic anatomy unsuited for renal sympathetic denervation
  • Estimated glomerular filtration rate <45 mL/min/1.73 m² (modification of diet in renal disease formula)
  • Unstable angina pectoris
  • Myocardial infarction within 6 months prior to randomization
  • Planned surgery or cardiovascular intervention within 6 months after randomization
  • Severe heart valve disease
  • Severe comorbidities with limited life expectancy
  • Pregnancy
  • Participation in another trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham procedureSham procedureSham procedure mimicking the renal sympathetic denervation procedure in the experimental arm
Renal sympathetic denervationRenal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA)Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA)
Primary Outcome Measures
NameTimeMethod
Change in systolic blood pressure (ABPM mean value)6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Leipzig Heart Center

🇩🇪

Leipzig, Germany

© Copyright 2025. All Rights Reserved by MedPath